20th Annual Industry/Academia Precision Oncology Symposium
Save the Date!
The Industry/Academia Precision Oncology Symposium is a unique forum uniting life science innovators from around the world to brainstorm translational oncology research.
On March 20-21, leaders in cancer research from around the world will gather for the 20th year of the Industry/Academia Precision Oncology Symposium, where they will engage with the latest high-impact science, multidisciplinary expertise, and evidence-based practices in pan-cancer treatment, research, and care. The symposium’s longevity speaks to its value in the oncology and biotech community, with many attendees joining year after year. Presentations and discussions focus on how recent developments in oncology translate into clinical applications and lifesaving therapeutic options for cancer patients. Hear from past symposium leaders and frequent attendees as they reflect and share their memories over the 20 years.
Duane Roth Achievement Award
The Duane Roth Achievement Award is bestowed at the UC San Diego Moores Cancer Center Industry/Academia Symposium. This prestigious award recognizes patient-focused leaders in healthcare whose groundbreaking work has successfully navigated scientific, financial, institutional, political, and cultural obstacles, thereby shaping new paradigms in research and treatment.
COI POLICY: DISCLOSURE OF RELATIONSHIPS WITH COMPANIES
The Symposium strives for independence, objectivity, transparency, and scientific rigor in all its activities through appropriate disclosure and management of financial relationships, among other things. The Symposium Policy for Relationships with Companies (COI Policy), in compliance with UC San Diego and University of California Office of the President (UCOP) COI policies (available at this link), was developed to help guide the management of potential conflicts, primarily through disclosure of all financial relationships that might result in actual, potential, or perceived conflicts of interest.
The Symposium requires participants in its activities—and all faculty and committee members— to disclose all of their financial relationships with for-profit health care companies. The Symposium’s Policy is not intended to create a presumption of impropriety based on the existence of financial relationships with companies, rather the goal is to achieve full transparency through the disclosure of those relationships. Although the Symposium Policy relies primarily on disclosure of financial relationships, it also recognizes that some relationships cannot be managed with disclosure alone and identifies additional management steps in this case.
The Symposium wants to help participants in its activities to successfully report their disclosures. To that end, the Symposium uses a general disclosure model, requiring disclosure of all relationships.